Literature DB >> 23530489

Notched QRS complex in lateral leads as a novel predictor of response to cardiac resynchronization therapy.

Wenzhi Pan1, Yangang Su, Wenqin Zhu, Xianhong Shu, Junbo Ge.   

Abstract

BACKGROUNDS: Notched QRS (nQRS) may be an indicator of ventricular delay. There are very few studies investigating the value of nQRS. The aim of the study was to identify the predictive value of nQRS for response to cardiac resynchronization therapy (CRT).
METHODS: Eighty-two patients with heart failure (HF) and widened QRS (≥120 ms) were implanted with a CRT device. nQRS was defined as presence of ≥2 R waves, or ≥1 notch in the R wave or S wave in ≥2 contiguous leads. Response to CRT was defined as percentage of left ventricular end-systolic volume (LVESV) reduction after 6 months CRT (ΔLVESV%) ≥15%.
RESULTS: nQRS was presented in 62 (76%) patients, 16 of whom had nQRS in anterior leads, 47 in inferior leads, and 42 in lateral leads. The rate of CRT response (65% vs 50%, P = 0.29) and ΔLVESV% (21.7 ± 31.7% vs 7.9 ± 25.4%, P = 0.09) were not different between patients with and without nQRS. But the rate of CRT response was higher in patients with nQRS in lateral leads (nQRS-L) than in those without nQRS-L (76% vs 45%, P = 0.006). ΔLVESV% was greater in patients with nQRS-L than in those without nQRS-L (25.2 ± 34.3% vs 10.1 ± 24.5%, P = 0.004). After adjusting for potential confounders including QRS duration, presence of nQRS-L still predicted positive CRT response (OR = 4.04, P = 0.009).
CONCLUSIONS: nQRS-L may be a novel predictor of response to CRT in patients with HF and widened QRS. Large-scale studies are needed to confirm this prognostic value of nQRS-L. ©2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23530489      PMCID: PMC6932172          DOI: 10.1111/anec.12008

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  23 in total

1.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy.

Authors:  Gabe B Bleeker; Jeroen J Bax; Jeffrey Wing-Hong Fung; Ernst E van der Wall; Qing Zhang; Martin J Schalij; Joseph Yat-Sun Chan; Cheuk-Man Yu
Journal:  Am J Cardiol       Date:  2005-11-28       Impact factor: 2.778

3.  Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease.

Authors:  Mithilesh K Das; Bilal Khan; Sony Jacob; Awaneesh Kumar; Jo Mahenthiran
Journal:  Circulation       Date:  2006-05-22       Impact factor: 29.690

4.  Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.

Authors:  Sjoerd A Mollema; Gabe B Bleeker; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2007-10-24       Impact factor: 2.778

Review 5.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Authors:  Borys Surawicz; Rory Childers; Barbara J Deal; Leonard S Gettes; James J Bailey; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Pentti M Rautaharju; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

6.  Agreement is poor among current criteria used to define response to cardiac resynchronization therapy.

Authors:  Brandon K Fornwalt; William W Sprague; Patrick BeDell; Jonathan D Suever; Bart Gerritse; John D Merlino; Derek A Fyfe; Angel R León; John N Oshinski
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

7.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Authors:  Wojciech Zareba; Helmut Klein; Iwona Cygankiewicz; W Jackson Hall; Scott McNitt; Mary Brown; David Cannom; James P Daubert; Michael Eldar; Michael R Gold; Jeffrey J Goldberger; Ilan Goldenberg; Edgar Lichstein; Heinz Pitschner; Mayer Rashtian; Scott Solomon; Sami Viskin; Paul Wang; Arthur J Moss
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

Review 8.  Right bundle branch block: varying electrocardiographic patterns. Aetiological correlation, mechanisms and electrophysiology.

Authors:  A K Agarwal; P Venugopalan
Journal:  Int J Cardiol       Date:  1999-09-30       Impact factor: 4.164

9.  Results of the Predictors of Response to CRT (PROSPECT) trial.

Authors:  Eugene S Chung; Angel R Leon; Luigi Tavazzi; Jing-Ping Sun; Petros Nihoyannopoulos; John Merlino; William T Abraham; Stefano Ghio; Christophe Leclercq; Jeroen J Bax; Cheuk-Man Yu; John Gorcsan; Martin St John Sutton; Johan De Sutter; Jaime Murillo
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

10.  Variable patterns of septal activation in patients with left bundle branch block and heart failure.

Authors:  Luz-Maria Rodriguez; Carl Timmermans; Ashish Nabar; Graydon Beatty; Hein J J Wellens
Journal:  J Cardiovasc Electrophysiol       Date:  2003-02
View more
  1 in total

1.  Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping.

Authors:  A M W van Stipdonk; M Mafi Rad; J G L M Luermans; H J Crijns; F W Prinzen; K Vernooy
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.